Hit3 also markedly improved the Nuc/Cyt ratio of RAN, despite a lack of difference between NL- and ALS-hiMNs under the untreated condition (Fig. 5A, B, D). Here, NUCB1 is linked to amyotrophic lateral sclerosis.